ISAR Bioscience GmbH is a translational research company founded 2018 in Planegg, Germany. Our goal is to overcome current limitations of stem cell research in order to advance discovery of novel therapeutics and industrial biotechnology products. We use iPSC (induced pluripotent stem cell) and genome engineering technologies to build the next generation of disease models as well as cell-based models for industrial biotechnology applications. ISAR will forge strategic partnerships with industry partners and translate academic achievements and ideas into industrial solutions and products. ISAR attracted an initial 20 Mio € funding from the Free State of Bavaria.